NVLN—the renamed AEGR/QLTI—implements 1:5 reverse split and buries the news within a PR on settling a class action lawsuit! https://globenewswire.com/news-release/2016/12/05/895081/0/en/Aegerion-Pharmaceuticals-a-Subsidiary-of-Novelion-Therapeutics-Enters-into-Agreement-in-Principle-to-Settle-Class-Action-Shareholder-Lawsuit.html Here are the slides from the 11/30/16 CC on the closing of the QLTI-AEGR merger: http://ir.novelion.com/common/download/download.cfm?companyid=AMDA-75YS1U&fileid=919411&filekey=D0095795-C2CB-48FA-A75A-CD323C4C338D&filename=NVLN_Closing_Slides_112916_Final.pdf